EBT
MRNA icon

Enterprise Bank & Trust’s Moderna MRNA Stock Holding History

Enterprise Bank & Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,160
Closed -$295K – 94
2021
Q4 		$295K Hold
1,160
– – 0.1% 80
2021
Q3 		$446K Hold
1,160
– – 0.18% 66
2021
Q2 		$273K Buy
+1,160
New +$207K 0.11% 79
2021
Q1 		– Sell
-3,135
Closed -$328K – 93
2020
Q4 		$328K Buy
+3,135
New +$317K 0.14% 73

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Enterprise Bank & Trust's MRNA Position: Q1 2022 in Review

Enterprise Bank & Trust sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,160 shares — an estimated $295K sold.

Enterprise Bank & Trust first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $446K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Enterprise Bank & Trust reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Enterprise Bank & Trust sold 1,160 Moderna shares in Q1 2022, an estimated $295K.
  • Enterprise Bank & Trust first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Enterprise Bank & Trust's Moderna position peaked at $446K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Enterprise Bank & Trust's 13F filing for Q1 2022, filed 13 Apr 2022.